SCHEMBL26225901

SCHEMBL26225901

CC(C)(C)[Si](C)(C)OC[C@H]1OC(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12769538 0.85 — —
SCHEMBL12049855 0.85 — —
SCHEMBL12151505 0.84 CYP2D6 (0.36) —
SCHEMBL12151506 0.81 — —
SCHEMBL19891559 0.81 — —
SCHEMBL19891516 0.81 — —
SCHEMBL23113791 0.81 L3MBTL1 (0.35) —
SCHEMBL20228547 0.80 — —
SCHEMBL9633277 0.80 — —
SCHEMBL20211426 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168329-A2 NOVEL PRODRUGS DERIVED FROM NICOTINIC ACID AND RIBOSE MITOPOWER, INC. (US) 2023-09-07 — — WO disclosed
Send feedback